Medicare Accreditation Resource Center |
Welcome to the NHIA member resource center on Medicare's accreditation requirements for Part B suppliers of Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS).
The Medicare Prescription Drug, Improvement and Modernization Act of 2003 (MMA) gave the Centers for Medicare & Medicaid Services (CMS) the authority to establish quality standards and accreditation requirements for all Part B DMEPOS suppliers. The Medicare Improvement for Patients and Providers Act of 2008 (MIPPA) included a statutory deadline for all Medicare DMEPOS suppliers to be accredited starting October 1, 2009.
Although the quality standards and accreditation requirements were included in statute in the same laws (MMA and MIPPA) that directed CMS to implement its competitive bidding program, most DMEPOS suppliers were required to be accredited by October 1, 2009 regardless of their involvement in the competitive bidding program. This included most home infusion therapy pharmacies that intended to treat Medicare Part B patients after the deadline. Most newly opening DMEPOS suppliers (including most newly opening home infusion pharmacies) are required to be accredited prior to receiving Medicare DMEPOS billing privileges.
This NHIA member resource center provides educational and reference materials available from NHIA and other sources on the Medicare Part B DMEPOS quality standards and accreditation program, as well as information on new developments in the transition to it. Check back periodically for updates to this NHIA resource center.
Tools and Resources
Medicare DMEPOS Quality Standards and Accreditation ![]()



